Please login to the form below

Not currently logged in
Email:
Password:

GSK in Sirtris takeover

Sirtris Pharmaceuticals has been taken over by GlaxoSmithKline (GSK) as part of an agreement involving the acquisition of the company's research portfolio through a cash tender offer of £11.33 per share
Sirtris Pharmaceuticals has been taken over by GlaxoSmithKline (GSK) as part of an agreement involving the acquisition of the company's research portfolio through a cash tender offer of £11.33 per share.

The agreement means GSK will pay Sirtris $720m (£362m), which specialises in the development of medicines to treat conditions related to the ageing process. Through the deal, GSK hopes to enhance its metabolic, neurological, immunologic and inflammation research capabilities.

Moncef Slaoui, chairman of GSK R&D, said: "This acquisition continues GSK's strategy of pursuing the best new science, externally or internally, to bring new medicines to patients and value to the GSK pipeline. Our intent is to retain all Sirtris employees and continue the entrepreneurial and innovative culture they created."

Sirtris will become part of GSK's drug discovery organisation and is expected to continue operating from its laboratories in Massachusetts, acting as an autonomous research unit.

Dr Christoph Westphal, CEO and vice-chair of Sirtris, said: "We expect this transaction will accelerate our vision to target sirtuins to treat diseases of metabolism and ageing and deliver tremendous value to patients, our shareholders and our employees."

6th May 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

segmentation_pie_thumb.jpg
If you’re not thinking segmentation, you’re not thinking
Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked
...

Infographics